Shattuck Labs (STTK) Capital Expenditures (2019 - 2026)
Shattuck Labs' (STTK) quarterly Capital Expenditures came in at $63000.0 in Q1 2026, down 11.27% on a QoQ basis from $71000.0 in Q3 2025.
Shattuck Labs (STTK) Capital Expenditures (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Capital Expenditures data on file, last reported at $63000.0 in Q1 2026.
- On a quarterly basis, Capital Expenditures changed N/A year-over-year to $63000.0 in Q1 2026; TTM through Mar 2026 was $134000.0, a 127.12% increase from a year earlier, with the FY2025 full-year figure at $71000.0, up 20.34% from the prior year.
- Capital Expenditures for Q1 2026 stood at $63000.0, down from $71000.0 in the prior quarter.
- Over the last five years, Capital Expenditures for STTK reached as high as $10.7 million in Q3 2022 and fell as low as -$2.3 million in Q2 2022.
- Historically, Capital Expenditures has averaged $1.0 million across 5 years, with a median of $67000.0 in 2025.
- Across the five-year window, Capital Expenditures sank 1576.92% in 2022 and surged 121.05% in 2024, its largest moves.
- Year by year, Capital Expenditures stood at $693000.0 in 2022, then slumped by 97.55% to $17000.0 in 2023, then soared by 147.06% to $42000.0 in 2024, then jumped by 69.05% to $71000.0 in 2025, then slipped by 11.27% to $63000.0 in 2026.
- Per Business Quant data, the three most recent Capital Expenditures figures were $63000.0 in Q1 2026, $71000.0 in Q3 2025, and $42000.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Shattuck Labs | 795.74 Mn | 795.74 Mn | - | 63,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 63,000.00 |
| Mar 31, 2026 | 63,000.00 |
| Sep 30, 2025 | 71,000.00 |
| Sep 30, 2025 | 71,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Sep 30, 2024 | 42,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Jun 30, 2024 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Dec 31, 2023 | 17,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Sep 30, 2023 | 19,000.00 |
| Jun 30, 2023 | 296,000.00 |
| Jun 30, 2023 | 296,000.00 |
| Mar 31, 2023 | 75,000.00 |
| Mar 31, 2023 | 75,000.00 |
| Dec 31, 2022 | 693,000.00 |
| Dec 31, 2022 | 693,000.00 |
| Sep 30, 2022 | 10.74 Mn |
| Sep 30, 2022 | 10.74 Mn |